Personalized Medicine in Metabolism Disorders

A special issue of Journal of Personalized Medicine (ISSN 2075-4426). This special issue belongs to the section "Mechanisms of Diseases".

Deadline for manuscript submissions: 10 October 2025 | Viewed by 15

Special Issue Editor


E-Mail Website
Guest Editor
Department of Nutritional Sciences, College of Human Sciences, Auburn University, Auburn, AL 36849, USA
Interests: metabolic and chronic diseases; metabolic syndrome; obesity; nutritional interventions

Special Issue Information

Dear Colleagues,

Metabolic disorders encompass a diverse range of conditions characterized by disruptions in cellular metabolism, which impact the processing of macronutrients and energy balance. These disorders have reached epidemic levels, with metabolic syndrome affecting approximately 20-25% of the global adult population.

While metabolic diseases often have a genetic predisposition, they may remain dormant until triggered by environmental or lifestyle factors. Since the late 1980s, the prevalence of metabolic syndrome has increased by over 35%, mirroring the rise in obesity, type 2 diabetes mellitus, and cardiovascular diseases. The concept of metabolic syndrome has evolved from early observations made by Kylin in the 1920s to its formal introduction as "Syndrome X" by Reaven in 1988. Organizations such as the World Health Organization (WHO) and the International Diabetes Federation (IDF) have subsequently refined its definition and diagnostic criteria.

Current research aims to clarify metabolic disorders' pathophysiological mechanisms, develop innovative preventive strategies, and enhance treatment modalities. This research involves a multidisciplinary approach, including nutritional interventions, physical activity programs, pharmacological treatments, and genetic profiling.

Recent studies have focused on the complex interactions between genetic predisposition, epigenetic modifications, gut microbiota composition, and lifestyle factors in metabolic health. Emerging areas of investigation include the modulation of adipose tissue function, particularly the activation of brown adipose tissue and the browning of white adipose tissue, as potential therapeutic targets. We welcome original research articles, systematic reviews, and meta-analyses that explore innovative methods for preventing, detecting, and treating metabolic disorders. Particular emphasis will be placed on studies examining personalized medicine strategies, novel biomarkers for early diagnosis, and lifestyle interventions that demonstrate efficacy in improving metabolic outcomes.

Dr. Mehrnaz Abbasi
Guest Editor

Manuscript Submission Information

Manuscripts should be submitted online at www.mdpi.com by registering and logging in to this website. Once you are registered, click here to go to the submission form. Manuscripts can be submitted until the deadline. All submissions that pass pre-check are peer-reviewed. Accepted papers will be published continuously in the journal (as soon as accepted) and will be listed together on the special issue website. Research articles, review articles as well as short communications are invited. For planned papers, a title and short abstract (about 100 words) can be sent to the Editorial Office for announcement on this website.

Submitted manuscripts should not have been published previously, nor be under consideration for publication elsewhere (except conference proceedings papers). All manuscripts are thoroughly refereed through a single-blind peer-review process. A guide for authors and other relevant information for submission of manuscripts is available on the Instructions for Authors page. Journal of Personalized Medicine is an international peer-reviewed open access monthly journal published by MDPI.

Please visit the Instructions for Authors page before submitting a manuscript. The Article Processing Charge (APC) for publication in this open access journal is 2600 CHF (Swiss Francs). Submitted papers should be well formatted and use good English. Authors may use MDPI's English editing service prior to publication or during author revisions.

Keywords

  • metabolic syndrome
  • obesity
  • insulin resistance
  • hypertension
  • type 2 diabetes
  • energy metabolism
  • fatty acid oxida-tion
  • gut microbiota
  • brown adipose tissue (BAT)
  • white adipose tissue (WAT)
  • nutritional interventions
  • lifestyle modifications
  • pharmacological treatments
  • phytochemicals
  • vitamins and supplements
  • public health
  • epidemiology of obesity
  • preventive strategies
  • genetic factors
  • metabolic health research
  • adipose tissue function

Benefits of Publishing in a Special Issue

  • Ease of navigation: Grouping papers by topic helps scholars navigate broad scope journals more efficiently.
  • Greater discoverability: Special Issues support the reach and impact of scientific research. Articles in Special Issues are more discoverable and cited more frequently.
  • Expansion of research network: Special Issues facilitate connections among authors, fostering scientific collaborations.
  • External promotion: Articles in Special Issues are often promoted through the journal's social media, increasing their visibility.
  • e-Book format: Special Issues with more than 10 articles can be published as dedicated e-books, ensuring wide and rapid dissemination.

Further information on MDPI's Special Issue polices can be found here.

Published Papers

This special issue is now open for submission.
Back to TopTop